Editas Medicine (EDIT) Gains from Sales and Divestitures (2016 - 2023)
Editas Medicine (EDIT) reported Gains from Sales and Divestitures of $210701.0 for Q2 2023, down 9.46% year-over-year from $232718.0 in Q2 2022, and up 44.11% on a QoQ basis from $146209.0 in Q1 2023.
Editas Medicine (EDIT) has 8 years of Gains from Sales and Divestitures data on file, last reported at $210701.0 in Q2 2023.
- Quarterly Gains from Sales and Divestitures fell 9.46% year-over-year to $210701.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $210701.0 (down 9.46% YoY) and the FY2022 annual result came in at $286642.0, up 7.25% from the prior year.
- Gains from Sales and Divestitures climbed to $210701.0 in Q2 2023 per EDIT's latest filing, from $146209.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $304638.0 in Q4 2020 and bottomed at $18000.0 in Q1 2019.
- The 5-year median for Gains from Sales and Divestitures is $200888.0 (2021), against an average of $179748.3.
- The widest annual swing landed in 2019, when Gains from Sales and Divestitures slumped 82.7%; it then jumped 1085.52% in 2020.
- Tracing EDIT's Gains from Sales and Divestitures over 5 years: stood at $99919.0 in 2019, then surged by 204.88% to $304638.0 in 2020, then decreased by 12.27% to $267268.0 in 2021, then grew by 7.25% to $286642.0 in 2022, then fell by 26.49% to $210701.0 in 2023.
- Per Business Quant, the three latest EDIT Gains from Sales and Divestitures figures stand at $210701.0 (Q2 2023), $146209.0 (Q1 2023), and $286642.0 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 210,701.00 |
| Jun 30, 2023 | 210,701.00 |
| Mar 31, 2023 | 146,209.00 |
| Mar 31, 2023 | 146,209.00 |
| Dec 31, 2022 | 286,642.00 |
| Dec 31, 2022 | 286,642.00 |
| Sep 30, 2022 | 271,037.00 |
| Sep 30, 2022 | 271,037.00 |
| Jun 30, 2022 | 232,718.00 |
| Jun 30, 2022 | 232,718.00 |
| Mar 31, 2022 | 154,834.00 |
| Mar 31, 2022 | 154,834.00 |
| Dec 31, 2021 | 267,268.00 |
| Dec 31, 2021 | 267,268.00 |
| Sep 30, 2021 | 191,075.00 |
| Sep 30, 2021 | 191,075.00 |
| Jun 30, 2021 | 117,187.00 |
| Jun 30, 2021 | 117,187.00 |
| Mar 31, 2021 | 79,397.00 |
| Mar 31, 2021 | 79,397.00 |
| Dec 31, 2020 | 304,638.00 |
| Dec 31, 2020 | 304,638.00 |
| Sep 30, 2020 | 279,326.00 |
| Sep 30, 2020 | 279,326.00 |
| Jun 30, 2020 | 243,587.00 |
| Jun 30, 2020 | 243,587.00 |
| Mar 31, 2020 | 213,393.00 |
| Mar 31, 2020 | 213,393.00 |
| Dec 31, 2019 | 99,919.00 |
| Dec 31, 2019 | 99,919.00 |
| Sep 30, 2019 | 77,052.00 |
| Sep 30, 2019 | 77,052.00 |
| Jun 30, 2019 | 42,486.00 |
| Jun 30, 2019 | 42,486.00 |
| Mar 31, 2019 | 18,000.00 |
| Mar 31, 2019 | 18,000.00 |
| Dec 31, 2018 | 243,225.00 |
| Dec 31, 2018 | 243,225.00 |
| Sep 30, 2018 | 225,225.00 |
| Sep 30, 2018 | 225,225.00 |
| Jun 30, 2018 | 207,225.00 |
| Jun 30, 2018 | 207,225.00 |
| Mar 31, 2018 | 104,025.00 |
| Mar 31, 2018 | 104,025.00 |
| Dec 31, 2017 | 784,119.00 |
| Dec 31, 2017 | 784,119.00 |
| Sep 30, 2017 | 556,560.00 |
| Sep 30, 2017 | 556,560.00 |
| Jun 30, 2017 | 394,485.00 |
| Jun 30, 2017 | 394,485.00 |
| Mar 31, 2017 | 208,293.00 |
| Mar 31, 2017 | 208,293.00 |
| Dec 31, 2016 | 774,215.00 |
| Dec 31, 2016 | 774,215.00 |
| Sep 30, 2016 | 580,662.00 |
| Sep 30, 2016 | 580,662.00 |
| Jun 30, 2016 | 387,109.00 |
| Jun 30, 2016 | 387,109.00 |
| Mar 31, 2016 | 193,551.00 |
| Mar 31, 2016 | 193,551.00 |